-+ 0.00%
-+ 0.00%
-+ 0.00%

Allogene Therapeutics Unveils Pivotal Phase 2 ALPHA3 Trial of Cema-cel in Large B-Cell Lymphoma

Reuters·11/03/2025 14:04:33

Please log in to view news